Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus dexmedetomidine for maintenance of anesthesia depth
IRCT20210415050976N5Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and ketamine in general anesthesia (3 arms), sponsored by Jahrom University of Medical Sciences. Primary endpoint: Depth of anesthesia. Started Sep 2021; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
general anesthesia
Beyond the preview
Go deeper on IRCT20210415050976N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050976N5.